Oct 26, 2026 07:00AM
Jul 8, 2026 08:00AM
Jul 8, 2026 08:00AM
May 7, 2026 08:00AM
Feb 6, 2026 08:00AM
Jan 12, 2026 02:00PM
Nov 24, 2025 08:00AM EMD Serono Takes Patient-Directed Approach to Bring Innovation to the Treatment of Rare Neuromuscular Disorder, Generalized Myasthenia Gravis
Oct 17, 2025 10:00AM
Oct 16, 2025 03:53PM
Oct 16, 2025 03:51PM
Sep 17, 2025 08:00AM
May 28, 2025 07:00AM
May 22, 2025 05:37PM
Apr 28, 2025 02:13AM Merck KGaA, Darmstadt, Germany to Acquire SpringWorks Therapeutics to Accelerate Sustainable Growth of Healthcare Business
Apr 24, 2025 03:32PM
Nov 12, 2024 01:18AM
Sep 12, 2024 08:00AM
Sep 10, 2024 08:00AM
May 23, 2024 05:00PM
May 22, 2024 01:35PM
Apr 16, 2024 08:00AM MilliporeSigma Launches First All-in-One Genetic Stability Assay to Accelerate Biosafety Testing
Feb 29, 2024 08:00AM
Jan 22, 2024 05:00PM
Oct 16, 2023 02:00AM
Oct 16, 2023 02:00AM
Oct 10, 2023 02:15AM
May 25, 2023 05:05PM
Mar 27, 2023 08:00AM Merck KGaA, Darmstadt, Germany Strengthens Oncology Franchise by Securing Exclusive Worldwide Rights to Anti PD-L1 Antibody BAVENCIO® (avelumab)
Feb 23, 2023 10:30AM
Feb 13, 2023 05:00PM
Oct 26, 2022 02:00AM
Sep 7, 2022 06:05PM
Sep 7, 2022 06:05PM
Jun 3, 2022 08:00AM
May 26, 2022 12:00PM EMD Serono to Present Latest Research From Oncology Portfolio at ASCO 2022
Mar 31, 2022 09:00AM
Feb 24, 2022 08:00AM
Feb 18, 2022 01:00PM
Feb 18, 2022 08:00AM
Feb 17, 2022 03:41PM
Dec 17, 2021 07:00AM
Oct 13, 2021 07:00AM New Real-World MAVENCLAD® Data Show Sustained Effectiveness and Benefit on Quality-of-Life Measures in RMS Patients
Oct 4, 2021 03:00AM
Sep 12, 2021 06:05PM
May 19, 2021 05:00PM
Apr 23, 2021 09:25AM
Feb 25, 2021 08:00AM
Feb 3, 2021 01:43PM
Jan 25, 2021 02:00AM European Commission Approves BAVENCIO® (avelumab) for First-Line Maintenance Treatment of Locally Advanced or Metastatic Urothelial Carcinoma
Dec 11, 2020 08:00AM

335,560 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All